|
?:authorAffiliation
|
-
[\'Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'The Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.\', \'Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'Sema4, a Mount Sinai Venture, Stamford, Connecticut, USA.\', \'Senior Scientific Affairs Manager, Infectious Diseases, Agena Bioscience, San Diego, California, USA.\', \'Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}